Cubist Pharmaceuticals Recent News
Global Hunter Initiates Cubist Pharmaceuticals At Neutral
UPDATE: Oppenheimer Color On CBST Upgrade
Oppenheimer Upgrades Cubist Pharmaceuticals To Outperform, $37 PT
Oppenheimer Maintains Perform on Cubist Pharmaceuticals (CBST)
Jefferies Comments On Cubist Pharmaceuticals 1Q Sales
Lazard Upgrades Cubist Pharmaceuticals To Buy, $33 PT
Needham Raises PT On Cubist Pharmaceuticals To $33
Wedbush Raises PT On Cubist Pharmaceuticals To $32
CBST Sales Rev Guidance 3-6% Higher Than Jefferies' Estimate
Cubist Pharmaceuticals 3Q EPS Report
3Q Results For CBST Report On 10/14